iAssay Wins AFWERX Phase 1 SBIR Award from U.S. Air Force

Innovative Program Aims to Improve Medical Testing Capabilities

San Diego, CA 04/29/2021- iAssay announced this week that they have been awarded a Phase 1 SBIR (Small Business Innovation Research) Award through AFWERX.  iAssay makes a patent-protected medical device called SimpleTest™ that can interpret test results and transmit preserved imaging and quantitative results electronically from point of care (PoC) and standard rapid diagnostic devices to doctors, laboratories, and other governmental agencies.

AFWERX is a United States Air Force program which aims to foster a culture of innovation within the service. Part of the AFWERX mission is to find innovative companies that can move with agility to bring leading-edge scientific capabilities and accelerate commercialization using military missions.  iAssay is part of an elite group of small businesses selected. “We are honored to work with the military and will strive to bring flexible, robust and improved medical testing, like SimpleTest™, to market,” said Lonnie Adelman, CEO and Founder of iAssay. “In addition to the Cloud-based data integration that SimpleTest provides, the device eliminates human error in the interpretation of test results.”

In Phase I, those businesses that are seen to hold the most promise are selected as sole source providers and participate in customer discovery and solutions for focus areas of the Air Force. The objective is to find a legitimate fit between new, nimble products and services that enable the Air Force to address solvable problems that align with their core goal and mission.    

Visit https://www.afwerx.af.mil for more details about the AFWERX program.
Visit https://www.iassay.net for more information about iAssay products and services.

                                                                       #      #        #

 Contact: Lonnie Adelman                              Email: info@iassay.net